Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77.

Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer. 2013 May; 14(3):224-9.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carcinoma, Non-Small-Cell Lung
Erlotinib Hydrochloride
Female
Humans
Lung Neoplasms
Male
Middle Aged
Quinazolines

authors with profiles

David J. Taber